Newsletter Archives

Showing 261 to 280 of 927 articles.

EBM Focus - Volume 15, Issue 37

Swimming in pooled data: A prospective meta-analysis of steroids for COVID-19

EBM Focus - Volume 15, Issue 36

Getting a leg up on sciatica: does early physical therapy referral help?

EBM Focus - Volume 15, Issue 35

Hey dipstick! A new screening option for albuminuria in patients with diabetes

MBE em foco - Volume 6, Issue 16

Pacientes negros podem estar sob risco aumentado de hospitalização e morte por COVID-19

EBM Focus - Volume 15, Issue 34

Returning to an old rhythm for atrial fibrillation?

Resident Focus - Volume 15, Issue 10

In patients with heart failure with reduced ejection fraction, dapagliflozin reduces risk of composite of worsening heart failure and cardiovascular death in both patients with or without diabetes

EBM Focus - Volume 15, Issue 33

Remdesivir for COVID: Remain skeptical

EBM Focus - Volume 15, Issue 32

Hot off the press: Heat and air pollution linked to poor pregnancy outcomes

MBE em foco - Volume 6, Issue 15

Programas de bem-estar no local de trabalho parecem ter pouco efeito sobre os desfechos de saúde dos empregados

EBM Focus - Volume 15, Issue 31

Collateral damage of COVID-19 pandemic stress

MBE em foco - Volume 6, Issue 14

Segure a faca - os antibióticos são uma opção razoável para a apendicite em crianças?

Resident Focus - Volume 15, Issue 9

Addition of fenofibrate to statins may reduce composite cardiovascular events in adults with metabolic syndrome

EBM Focus - Volume 15, Issue 30

Bold new recommendations for cervical cancer screening

MBE em foco - Volume 6, Issue 13

Cinco coisas que você deveria saber sobre os testes de anticorpos para COVID-19

EBM Focus - Volume 15, Issue 29

Narrow external validation of the Hematuria Risk Index

MBE em foco - Volume 6, Issue 12

Marcadores intermediários na gestação: deveríamos adotar novas diretrizes sugerindo parto cesáreo para HSV no terceiro trimestre?

EBM Focus - Volume 15, Issue 28

Hydroxychloroquine still of unproven benefit for COVID-19

EBM Focus - Volume 15, Issue 27

Headline or hypothesis? ACE inhibitors/ARBs and decreased colon cancer risk

Resident Focus - Volume 15, Issue 8

Acetazolamide 62.5 mg twice daily may be as effective as standard dose (125 mg twice daily) for reducing the risk of acute mountain sickness

EBM Focus - Volume 15, Issue 26

Five things you should know about COVID-19 antibody testing